A compelling new study is claiming to have uncovered the missing link explaining how gum disease is associated with diabetes, cardiovascular disease and even Alzheimer’s. The research demonstrates how periodontitis can initiate a systemic immune respon… Continue reading How gum disease can influence heart disease, diabetes and even Alzheimer’s
Research from Washington State University (WSU), and published in The Journal of Affective Disorders, is reporting some people find their symptoms of obsessive-compulsive disorder (OCD) dramatically drop after smoking cannabis. The study suggests the i… Continue reading Cannabis may reduce acute OCD symptoms, but long-term effects unclear
Researchers in the United Kingdom are set to undertake controversial human challenge trials to accelerate the testing of COVID-19 vaccines. The trials, planned to commence in January 2021, will initially begin by deliberately infecting young and health… Continue reading UK to begin trials infecting healthy volunteers with COVID in early 2021
A large team of cancer researchers in The Netherlands has made a surprising new discovery, finding a pair of previously unknown salivary glands. Nestled deep in the back of the nasopharynx, the discovery may help prevent damaging side effects from head… Continue reading Previously unknown saliva glands discovered deep inside the human head
A new study investigating the relationship between the gut microbiome, genetics, and multiple sclerosis, is suggesting bacteria certainly plays a role in modulating the effects of the disease but whether that role is positive or negative may be fundame… Continue reading Multiple sclerosis and the microbiome: Study suggests complex relationship
An experimental drug treating amyotrophic lateral sclerosis (ALS) is demonstrating promising potential, both slowing the progression of this neurodegenerative disease and prolonging patient survival. Phase 2 human trials are complete and Amylyx Pharmaceuticals, the company developing the treatment, says it is working with regulatory bodies on the steps necessary to bring the drug to market ahead of a Phase 3 trial.
A growing body of research is beginning to suggest severe apathy in older adults is an early sign of dementia. New research from the University of California, San Francisco, with support from the National Institute on Aging, is now offering one of the first longitudinal studies to show apathy could be an early visible symptom of cognitive decline.
Researchers from Tufts University have genetically engineered bovine cells to produce lab-grown beef containing beta-carotene, a plant nutrient that is converted into vitamin A in the human body. The researchers suggest lab-grown meats in the future co… Continue reading Lab-grown meat can be genetically enhanced with plant nutrients
A pair of newly published studies are demonstrating how passive smartphone data can be used to effectively predict relapse episodes in schizophrenia patients. The research used machine learning to analyze behavioral data and predict schizophrenic relap… Continue reading Machine learning predicts schizophrenia relapses using smartphone data
An intriguing new animal study, led by researchers from the University of Southern California, is suggesting a hunger-regulating hormone secreted from the stomach may also influence memory and cognitive function. The study builds on a growing body of r… Continue reading Gut-brain study reveals impact of hunger hormone on memory